Abstract
A 47-year-old previously healthy man presented with acute moderate flank pain. Evaluation revealed left renal cell carcinoma, with inferior vena cava tumour thrombus invasion. Patient had no significant history or risk factors to pre-dispose him to genitourinary cancers. Surgery was deemed to not be appropriate due to distant metastases, but patient received targeted molecular therapy and immunotherapy with striking regression of the thrombus.
Original language | English (US) |
---|---|
Article number | e227030 |
Journal | BMJ case reports |
Volume | 12 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2019 |
Keywords
- cancer intervention
- immunological products and vaccines
- urological surgery
- urology
ASJC Scopus subject areas
- Medicine(all)